Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stem cells within the bone marrow (BM) exist in a quiescent state or are instructed to differentiate and mobilize to circulation following specific signals. Matrix metalloproteinase-9 (MMP-9), induced in BM cells, releases soluble Kit-ligand (sKitL), permitting the transfer of endothelial and hematopoietic stem cells (HSCs) from the quiescent to proliferative niche. BM ablation induces SDF-1, which upregulates MMP-9 expression, and causes shedding of sKitL and recruitment of c-Kit+ stem/progenitors. In MMP-9-/- mice, release of sKitL and HSC motility are impaired, resulting in failure of hematopoietic recovery and increased mortality, while exogenous sKitL restores hematopoiesis and survival after BM ablation. Release of sKitL by MMP-9 enables BM repopulating cells to translocate to a permissive vascular niche favoring differentiation and reconstitution of the stem/progenitor cell pool.

Original publication

DOI

10.1016/s0092-8674(02)00754-7

Type

Journal article

Journal

Cell

Publication Date

31/05/2002

Volume

109

Pages

625 - 637

Keywords

Animals, Bone Marrow, Cell Differentiation, Cell Movement, Cells, Cultured, Chemokine CXCL12, Chemokines, Chemokines, CXC, Endothelial Growth Factors, Female, Fluorouracil, Hematopoietic Stem Cells, Immunosuppressive Agents, Lymphokines, Male, Matrix Metalloproteinase 9, Megakaryocytes, Mice, Mice, Knockout, Mice, SCID, Myeloid Cells, Recovery of Function, Stem Cell Factor, Stem Cells, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors